The phenion® full-thickness skin model for percutaneous absorption testing

Skin Pharmacology and Physiology

Volumn 23, Issue 2, 2010, Pages 105-112

  Ackermann, K ^a   Lombardi Borgia, S ^a   Korting, H C ^b   Mewes, K R ^c   Schäfer Korting, Monika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HENKEL KGAA   (Germany)

Author keywords

Full thickness skin model; Percutaneous absorption; Reconstructed human epidermis; Skin permeation, OECD standard compounds

Indexed keywords

BENZOIC ACID; CAFFEINE; NICOTINE; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; EXPERIMENTAL MODEL; EXPERIMENTAL PIG; FULL THICKNESS SKIN MODEL; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION; ANIMAL; ANIMAL TESTING ALTERNATIVE; BIOLOGICAL MODEL; COMPARATIVE STUDY; HUMAN; METHODOLOGY; PERMEABILITY; SPECIES DIFFERENCE; SWINE;

ANIMAL TESTING ALTERNATIVES; ANIMALS; BENZOIC ACID; CAFFEINE; HUMANS; MODELS, BIOLOGICAL; NICOTINE; PERMEABILITY; SKIN ABSORPTION; SPECIES SPECIFICITY; SWINE; TESTOSTERONE;

EID: 72049101914     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265681     Document Type: Article

References (31)

1. OECD: Skin absorption: in vitro method. Guideline 428. 2004.
2. OECD: Guidance document No 28 for the conduct of skin absorption studies. 35th Joint Meeting, August 2003.
3. Hartung T, Bremer S, Casati S, Coecke S, Corvi R, Fortaner S, Gribaldo L, Halder M, Hoffmann S, Roi AJ, Prieto P, Sabbioni E, Scott L, Worth A, Zuang V: A modular approach to the ECVAM principles on test validity. Altern Lab Anim 2004; 32: 467-472.
4. Schäfer-Korting M, Bock U, Diembeck W, Düsing HJ, Gamer A, Haltner-Ukomadu E, Hoffmann C, Kaca M, Kamp H, Kersen S, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Müller- Goymann C, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Spielmann H, Vuia A, Weimer M: The use of reconstructed human epidermis for skin absorption testing: results of the validation study. Altern Lab Anim 2008; 36: 161-187.
5. Schäfer-Korting M, Bock U, Gamer A, Haberland A, Haltner-Ukomadu E, Kaca M, Kamp H, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Schröder KR, Spielmann H, Vuia A: Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. Altern Lab Anim 2006; 34: 283-294.
6. OECD: Test guideline 431: in vitro skin corrosion: human skin model test. April 13, 2004.
7. Spielmann H, Grune B, Liebsch M, Seiler A, Vogel R: Successful validation of in vitro methods in toxicology by ZEBET, the national centre for alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Exp Toxicol Pathol 2008; 60: 225-233.
8. Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C, Roguet R, Cotovio J, Cole T, Worth A, Heylings J, Jones P, Robles C, Kandarova H, Gamer A, Remmele M, Curren R, Raabe H, Cockshott A, Gerner I, Zuang V: The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the Episkin and Epiderm assays and on the skin integrity function test. Altern Lab Anim 2007; 35: 559-601.
9. Kandarova H, Hayden P, Klausner M, Kubilus J, Sheasgreen J: An in vitro skin irritation test (SIT) using the Epiderm reconstructed human epidermal (RHE) model. J Vis Exp 2009; doi: 10.3791/1366.
10. Mewes KR, Raus M, Bernd A, Zoller NN, Sattler A, Graf R: Elastin expression in a newly developed full-thickness skin equivalent. Skin Pharmacol Physiol 2007; 20: 85-95.
11. Zöller NN, Kippenberger S, Thaci D, Mewes K, Spiegel M, Sattler A, Schultz M, Bereiter- Hahn J, Kaufmann R, Bernd A: Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol In Vitro 2008; 22: 747-759.
12. Hu T, Bailey RE, Morrall SW, Aardema MJ, Stanley LA, Skare JA: Dermal penetration and metabolism of p -aminophenol and p - phenylenediamine: application of the Epiderm human reconstructed epidermis model. Toxicol Lett 2009; 188: 119-129.
13. Kubota K, Ademola J, Maibach HI: Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent. J Pharm Sci 1995; 84: 1478-1481.
14. Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-Korting M: In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Eur J Pharm Biopharm 2008; 68: 380-389.
15. Schäfer-Korting M, Mahmoud A, Lombardi Borgia S, Brüggener B, Kleuser B, Schreiber S, Mehnert W: Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation. Altern Lab Anim 2008; 36: 441-452.
16. Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Schäfer-Korting M: Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm Res 1999; 16: 1386-1391.
17. Gysler A, Lange K, Korting HC, Schäfer- Korting M: Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm Res 1997; 14: 793-797.
18. Münster U, Hammer S, Blume-Peytavi U, Schäfer-Korting M: Testosterone metabolism in human skin cells in vitro and its interaction with estradiol and dutasteride. Skin Pharmacol Appl Skin Physiol 2003; 16: 356-366.
19. Curren RD, Mun GC, Gibson DP, Aardema MJ: Development of a method for assessing micronucleus induction in a 3D human skin model (Epiderm). Mutat Res 2006; 607: 192-204.
20. Reisinger K, Wiegand C, Scheel J, Schroeder K, Eschrich D: Genotoxicity testing and metabolism studies using the Phenion full thickness skin model. 6th World Congress On Alternatives Anim Use Life Sci, Tokyo, 2007.
21. Netzlaff F, Kaca M, Bock U, Haltner-Ukomadu E, Meiers P, Lehr CM, Schaefer UF: Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations. Eur J Pharm Biopharm 2007; 66: 127-134.
22. Schreiber S, Mahmoud A, Vuia A, Rübbelke MK, Schmidt E, Schaller M, Kandarova H, Haberland A, Schäfer UF, Bock U, Korting HC, Liebsch M, Schäfer-Korting M: Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro 2005; 19: 813-822.
23. Karnovsky MJ: A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol 1965; 27: 137A.
24. Luft JH: Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 1961; 9: 409-414.
25. Jaeckle E, Schaefer UF, Loth H: Comparison of effects of different ointment bases on the penetration of ketoprofen through heat-separated human epidermis and artificial lipid barriers. J Pharm Sci 2003; 92: 1396-1406.
26. Moss GP, Dearden JC, Patel H, Cronin MT: Quantitative structure-permeability relationships (QSPRS) for percutaneous absorption. Toxicol In Vitro 2002; 16: 299-317.
27. Niedorf F, Schmidt E, Kietzmann M: The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data. Altern Lab Anim 2008; 36: 201-213.
28. Kaca M, Bock U, Tawfik Jalal M, Harms M, Hoffmann C, Muller-Goymann C, Netzlaff F, Schafer U, Lehr CM, Haltner-Ukomadu E: The physicochemical parameters of marker compounds and vehicles for use in in vitro percutaneous absorption studies. Altern Lab Anim 2008; 36: 189-200.
29. Schmook FP, Meingassner JG, Billich A: Comparison of human skin or epidermis models with human and animal skin in invitro percutaneous absorption. Int J Pharm 2001; 215: 51-56.
30. Haberland A, Schreiber S, Santos Maia C, Rübbelke MK, Schaller M, Korting HC, Kleuser B, Schimke I, Schäfer-Korting M: The impact of skin viability on drug metabolism and permeation - BSA toxicity on primary keratinocytes. Toxicol In Vitro 2006; 20: 347-354.
31. Antille C, Tran C, Sorg O, Saurat JH: Penetration and metabolism of topical retinoids in ex vivo organ-cultured full-thickness human skin explants. Skin Pharmacol Physiol 2004; 17: 124-128.